Page 12 - String Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NanoString Technologies (NASDAQ:NSTG – Get Free Report) and Nephros (NASDAQ:NEPH – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, earnings, analyst recommendations and dividends. Insider & Institutional Ownership 94.1% of NanoString Technologies […]

August Issue of Lancet Medical Journal Features Breakthrough Study Decoding Immunological Challenges of Xenotransplantation ...

Stock analysts at StockNews.com assumed coverage on shares of NanoString Technologies (NASDAQ:NSTG – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. NSTG has been the topic of several other reports. Morgan Stanley dropped their price target on NanoString […]

NanoString Technologies, Inc. , a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast presentations from...

NanoString Technologies (NASDAQ:NSTG – Get Free Report) released its earnings results on Thursday. The biotechnology company reported ($0.92) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.70) by ($0.22), Briefing.com reports. The firm had revenue of $44.16 million during the quarter, compared to analyst estimates of $42.45 million. NanoString Technologies had […]